Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous cytotoxic T lymphocytes exposed to dendritic cells loaded with 6B11 anti-idiotype minibody

A preparation of autologous cytotoxic T lymphocytes (CTLs) that are exposed, ex vivo, to autologous dendritic cells (DCs) loaded with the anti-idiotype minibody 6B11, which mimics the epithelial ovarian tumor-associated antigen (TAA), OC166-9, with potential immunostimulatory and antineoplastic activities. Upon administration, the CTLs exposed to DCs loaded with 6B11 anti-idiotype minibody target and kill autologous ovarian cells expressing the TAA.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:6B11 anti-idiotype minibody-pulsed DCs induced autologous CTLs
autologous CTLs exposed to 6B11-OCIK
autologous CTLs exposed to 6B11mini-ovarian-cytokine-induced-killer cells
autologous CTLs induced with 6B11 anti-idiotype minibody-pulsed DCs
autologous cytotoxic T cells induced by autologous dendritic cells loaded with 6B11 anti-idiotype minibody
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search